litlas
ログインアカウント作成

Alan W. Partin

1989–2024 年に発表

別表記
Alan W Partin
222
論文数
47,932
被引用数
115
h 指数
221
i10 指数

被引用数

Alan W. Partin の年別被引用数1952 年: 被引用 1 件1985 年: 被引用 3 件1989 年: 被引用 1 件1990 年: 被引用 8 件1991 年: 被引用 24 件1992 年: 被引用 18 件1993 年: 被引用 50 件1994 年: 被引用 83 件1995 年: 被引用 99 件1996 年: 被引用 115 件1997 年: 被引用 176 件1998 年: 被引用 228 件1999 年: 被引用 247 件2000 年: 被引用 325 件2001 年: 被引用 355 件2002 年: 被引用 264 件2003 年: 被引用 400 件2004 年: 被引用 333 件2005 年: 被引用 304 件2006 年: 被引用 326 件2007 年: 被引用 378 件2008 年: 被引用 426 件2009 年: 被引用 382 件2010 年: 被引用 336 件2011 年: 被引用 357 件2012 年: 被引用 366 件2013 年: 被引用 331 件2014 年: 被引用 349 件2015 年: 被引用 263 件2016 年: 被引用 330 件2017 年: 被引用 265 件2018 年: 被引用 267 件2019 年: 被引用 827 件2020 年: 被引用 808 件2021 年: 被引用 825 件2022 年: 被引用 505 件2023 年: 被引用 371 件2024 年: 被引用 539 件2025 年: 被引用 212 件2026 年: 被引用 11 件1953〜1984 年は被引用が無いため表示していません1986〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,234 件、この内訳の 34.1%中国: 引用元論文 751 件、この内訳の 6%イギリス: 引用元論文 745 件、この内訳の 6%ドイツ: 引用元論文 682 件、この内訳の 5.5%カナダ: 引用元論文 657 件、この内訳の 5.3%イタリア: 引用元論文 596 件、この内訳の 4.8%オランダ: 引用元論文 419 件、この内訳の 3.4%フランス: 引用元論文 379 件、この内訳の 3%オーストラリア: 引用元論文 358 件、この内訳の 2.9%スウェーデン: 引用元論文 300 件、この内訳の 2.4%日本: 引用元論文 299 件、この内訳の 2.4%スペイン: 引用元論文 219 件、この内訳の 1.8%
0%34.1%その他 22.4%

機関

分野

  • Medicine68.9%
  • Biochemistry, Genetics and Molecular Biology22.5%
  • Immunology and Microbiology1.7%
  • Computer Science1.5%
  • Chemistry1.5%
  • Engineering1.4%
  • その他2.5%

トピック

  • Prostate Cancer Treatment and Research17.8%
  • Prostate Cancer Diagnosis and Treatment16.3%
  • Urologic and reproductive health conditions2.1%
  • Urinary Bladder and Prostate Research2%
  • Cancer, Lipids, and Metabolism2%
  • Advanced Radiotherapy Techniques1.8%
  • その他58%

共著者

全論文

検索で開く
  1. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy

    著者: James McKiernan, Michael Donovan, Vince O’Neill, Stefan Bentink, Mikkel Noerholm, Susan Belzer, Johan Skog, Michael W. Kattan, Alan W. Partin, Gerald L. Andriole, Gordon Brown, John T. Wei, Ian M. Thompson, Peter R. Carroll - JAMA Oncology 2016 被引用: 666

  2. Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer

    著者: Eva Shrestha, James R. White, Shu-Han Yu, İbrahim Kulaç, Onur Ertunç, Angelo M. De Marzo, Srinivasan Yegnasubramanian, Leslie A. Mangold, Alan W. Partin, Karen S. Sfanos - The Journal of Urology 2017 被引用: 271

  3. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10 ng/ml at Initial Biopsy

    著者: James McKiernan, Michael Donovan, Eric Margolis, Alan W. Partin, Ballentine Carter, Gordon Brown, Phillipp Torkler, Mikkel Noerholm, Johan Skog, Neal D. Shore, G.L. Andriole, Ian M. Thompson, Peter R. Carroll - European Urology 2018 被引用: 281

  4. Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy

    著者: Stephen J. Freedland, Elizabeth B. Humphreys, Leslie A. Mangold, Mario A. Eisenberger, Frederick J. Dorey, Patrick C. Walsh, Alan W. Partin - JAMA 2005 被引用: 1,358

  5. Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

    著者: Rong Hu, Thomas A. Dunn, Shuanzeng Wei, Sumit Isharwal, Robert W. Veltri, Elizabeth B. Humphreys, Misop Han, Alan W. Partin, Robert L. Vessella, William B. Isaacs, G. Steven Bova, Jun Luo - Cancer Research 2008 被引用: 1,072

  6. T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer

    著者: Aleksandar Obradović, Matthew C. Dallos, Marianna Zahurak, Alan W. Partin, Edward M. Schaeffer, Ashley E. Ross, Mohamad E. Allaf, Thomas R. Nirschl, David Liu, Carolyn G. Chapman, Tanya O’Neal, Haiyi Cao, Jennifer N. Durham, Güneş Güner, Javier Baena-Del Valle, Onur Ertunç, Angelo M. De Marzo, Emmanuel S. Antonarakis, Charles G. Drake - Clinical Cancer Research 2020 被引用: 114

  7. Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies

    著者: Erik Margolis, Gordon Brown, Alan W. Partin, Ballentine Carter, James McKiernan, Ronald Tutrone, Phillipp Torkler, Christian Fischer, Vasisht Tadigotla, Mikkel Noerholm, Michael Donovan, Johan Skog - Prostate Cancer and Prostatic Diseases 2021 被引用: 100

  8. Germline Mutations in HOXB13 and Prostate-Cancer Risk

    著者: Charles M. Ewing, Anna M. Ray, Ethan M. Lange, Kimberly A. Zuhlke, Christiane M. Robbins, Waibhav Tembe, Kathleen E. Wiley, Sarah D. Isaacs, Dorhyun Johng, Yunfei Wang, Chris Bizon, Guifang Yan, Marta Gielzak, Alan W. Partin, Vijayalakshmi Shanmugam, Tyler Izatt, Shripad Sinari, David W. Craig, Shusen Zheng, Patrick C. Walsh, James E. Montie, Jianfeng Xu, John D. Carpten, William B. Isaacs, Kathleen A. Cooney - New England Journal of Medicine 2012 被引用: 670

  9. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

    著者: Rong Na, Shusen Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M. Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz, Kamalakar Gulukota, Donald L. Helseth, Margo Quinn, Elizabeth Humphries, Kathleen E. Wiley, Sarah D. Isaacs, Yishuo Wu, Xu Liu, Ning Zhang, Chi-Hsiung Wang, Janardan D. Khandekar, Peter J. Hulick, Daniel H. Shevrin, Kathleen A. Cooney, Zhoujun Shen, Alan W. Partin, H. Ballentine Carter, Michael A. Carducci, Mario A. Eisenberger, S. Denmeade, Michael McGuire, Patrick C. Walsh, Brian T. Helfand, Charles B. Brendler, Qiang Ding, Jianfeng Xu, William B. Isaacs - European Urology 2016 被引用: 341

  10. Prognostic G leason grade grouping: data based on the modified G leason scoring system

    著者: Phillip M. Pierorazio, Patrick C. Walsh, Alan W. Partin, Jonathan I. Epstein - British Journal of Urology 2013 被引用: 629

  11. Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death

    著者: Derya Tilki, Ming‐Hui Chen, Jing Wu, Hartwig Huland, Markus Graefen, Thomas Wiegel, Dirk Böhmer, Osama Mohamad, Janet E. Cowan, Felix Y. Feng, Peter R. Carroll, Bruce J. Trock, Alan W. Partin, Anthony V. D’Amico - Journal of Clinical Oncology 2021 被引用: 110

  12. The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer

    著者: Stacy Loeb, Martin G. Sanda, Dennis L. Broyles, Sanghyuk S. Shin, Chris H. Bangma, John T. Wei, Alan W. Partin, George G. Klee, Kevin M. Slawin, Leonard S. Marks, Ron H. N. van Schaik, Daniel W. Chan, Lori J. Sokoll, Amabelle B. Cruz, Isaac Mizrahi, William J. Catàlona - The Journal of Urology 2014 被引用: 294

  13. Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?

    著者: John T. Wei, Ziding Feng, Alan W. Partin, Elissa C. Brown, Ian M. Thompson, Lori J. Sokoll, Daniel W. Chan, Yair Lotan, Adam S. Kibel, J. Erik Busby, Mohamed Bidair, Daniel W. Lin, Samir S. Taneja, Rosalia Viterbo, Aron Y. Joon, Jackie Dahlgren, Jacob Kagan, Sudhir Srivastava, Martin G. Sanda - Journal of Clinical Oncology 2014 被引用: 274

  14. A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

    著者: William J. Catàlona, Alan W. Partin, Martin G. Sanda, John T. Wei, George G. Klee, Chris H. Bangma, Kevin M. Slawin, Leonard S. Marks, Stacy Loeb, Dennis L. Broyles, Sanghyuk S. Shin, Amabelle B. Cruz, Daniel W. Chan, Lori J. Sokoll, William L. Roberts, Ron H. N. van Schaik, Isaac Mizrahi - The Journal of Urology 2011 被引用: 493

  15. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men

    著者: Ashley E. Ross, Michael H. Johnson, Kasra Yousefi, Elai Davicioni, George J. Netto, Luigi Marchionni, Helen Fedor, Stephanie Glavaris, Voleak Choeurng, Christine Buerki, Nicholas Erho, Lucia L.C. Lam, Elizabeth B. Humphreys, Sheila F. Faraj, Stephania Martins Bezerra, Misop Han, Alan W. Partin, Bruce J. Trock, Edward M. Schaeffer - European Urology 2015 被引用: 247

  16. Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer

    著者: Martin G. Sanda, Ziding Feng, David H. Howard, Scott A. Tomlins, Lori J. Sokoll, Daniel W. Chan, Meredith M. Regan, Jack Groskopf, Jonathan Chipman, Dattatraya Patil, Simpa S. Salami, Douglas S. Scherr, Jacob Kagan, Sudhir Srivastava, Ian M. Thompson, Javed Siddiqui, Jing Fan, Aron Y. Joon, Leonidas E. Bantis, Mark A. Rubin, Arul M. Chinnayian, John T. Wei, and the EDRN-PCA3 Study Group, Mohamed Bidair, Adam S. Kibel, Daniel Lin, Yair Lotan, Alan W. Partin, Samir S. Taneja - JAMA Oncology 2017 被引用: 158

  17. Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease

    著者: William J. Catalona, Alan W. Partin, Kevin M. Slawin, Michael K. Brawer, Robert C. Flanigan, Anup Patel, Jerome P. Richie, Jean B. deKernion, Patrick C. Walsh, Peter T. Scardino, Paul H. Lange, Eric N.P. Subong, Robert E. Parson, Gail H. Gasior, Kathleen G Loveland, Paula C. Southwick - JAMA 1998 被引用: 1,170

  18. Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk

    著者: Jason Michaud, Kevin L. Billups, Alan W. Partin - Therapeutic Advances in Urology 2015 被引用: 137

  19. Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy

    著者: Scott E. Eggener, Peter T. Scardino, Patrick C. Walsh, Misop Han, Alan W. Partin, Bruce J. Trock, Zhaoyong Feng, David P. Wood, James A. Eastham, Ofer Yossepowitch, Danny Rabah, Michael W. Kattan, Changhong Yu, Eric A. Klein, Andrew J. Stephenson - The Journal of Urology 2011 被引用: 642

  20. The natural history of metastatic progression in men with prostate‐specific antigen recurrence after radical prostatectomy: long‐term follow‐up

    著者: Emmanuel S. Antonarakis, Zhaoyong Feng, Bruce J. Trock, Elizabeth B. Humphreys, Michael A. Carducci, Alan W. Partin, Patrick C. Walsh, Mario A. Eisenberger - British Journal of Urology 2011 被引用: 274

  21. PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients

    著者: Tamara L. Lotan, Bora Gürel, Siobhan Sutcliffe, David Esopi, Wennuan Liu, Jianfeng Xu, Jessica Hicks, Ben Ho Park, Elizabeth B. Humphreys, Alan W. Partin, Misop Han, George J. Netto, William B. Isaacs, Angelo M. De Marzo - Clinical Cancer Research 2011 被引用: 350

  22. Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies

    著者: Alan W. Partin, Leander Van Neste, Eric A. Klein, Leonard S. Marks, Jason Gee, Dean A. Troyer, Kimberly Rieger‐Christ, J. Stephen Jones, Cristina Magi‐Galluzzi, Leslie A. Mangold, Bruce J. Trock, Raymond S. Lance, Joseph Bigley, Wim Van Criekinge, Jonathan I. Epstein - The Journal of Urology 2014 被引用: 225

  23. Risk score predicts high‐grade prostate cancer in DNA‐methylation positive, histopathologically negative biopsies

    著者: Leander Van Neste, Alan W. Partin, Grant D. Stewart, Jonathan I. Epstein, David J. Harrison, Wim Van Criekinge - The Prostate 2016 被引用: 95

  24. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer

    著者: Jeffrey J. Tosoian, Yuping Zhang, Lanbo Xiao, Cassie Xie, Nathan L. Samora, Yashar S. Niknafs, Zoey Chopra, Javed Siddiqui, Heng Zheng, Grace Herron, Neil Vaishampayan, Hunter S. Robinson, Kumaran Arivoli, Bruce J. Trock, Ashley E. Ross, Todd M. Morgan, Ganesh S. Palapattu, Simpa S. Salami, Lakshmi P. Kunju, Scott A. Tomlins, Lori J. Sokoll, Daniel W. Chan, Sudhir Srivastava, Ziding Feng, Martin G. Sanda, Yingye Zheng, John T. Wei, Arul M. Chinnaiyan, EDRN-PCA3 Study Group, Ian M. Thompson, Mohamed Bidair, Adam S. Kibel, Daniel W. Lin, Yair Lotan, Alan W. Partin, Samir S. Taneja, David H. Howard, Meredith M. Regan, Jack Groskopf, Jonathan Chipman, Dattatraya Patil, Douglas S. Scherr, Jacob Kagan, Jing Fan, Aron Y. Joon, Leonidas E. Bantis, Mark A. Rubin - JAMA Oncology 2024 被引用: 54